Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease Active Biotech, 14 Aug 2014 Accessed on 19 Aug 2014 from https://www.activebiotech.com/press-releases-1?pressurl=http://cws.huginonline.com/A/1002/PR/201408/1848747.xml. CommentRecommendBookmarkWatch